{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T02:08:16Z","timestamp":1768442896040,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":890,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Genzyme pharmaceutical"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.bbmt.2012.06.004","type":"journal-article","created":{"date-parts":[[2012,6,18]],"date-time":"2012-06-18T01:15:27Z","timestamp":1339982127000},"page":"1734-1744","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Anti-Thymocyte Globulin (Thymoglobulin), Tacrolimus, and Sirolimus as Acute Graft-versus-Host Disease Prophylaxis for Unrelated Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"18","author":[{"given":"Zaid","family":"Al-Kadhimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zartash","family":"Gul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daryn","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muneer","family":"Abidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lois","family":"Ayash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhinav","family":"Deol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Lum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Forman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Voravit","family":"Ratanatharathorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Uberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2012.06.004_bib1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00277-011-1299-8","article-title":"Allogeneic bone marrow transplantation compared to peripheral blood stem\u00a0cell transplantation for the treatment of hematologic malignancies: a meta-analysis based on time-to-event data from randomized controlled trials","volume":"91","author":"Chang","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2012.06.004_bib2","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.bbmt.2010.07.022","article-title":"One-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typing","volume":"17","author":"Valc\u00e1rcel","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.06.004_bib3","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood.V99.6.1971","article-title":"Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation","volume":"99","author":"Weisdorf","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.06.004_bib4","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1182\/blood-2007-06-097386","article-title":"High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation","volume":"110","author":"Lee","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.06.004_bib5","first-page":"2062","article-title":"Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors","volume":"96","author":"Nash","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.06.004_bib6","first-page":"2303","article-title":"Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation","volume":"92","author":"Ratanatharathorn","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.06.004_bib7","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1182\/blood.V73.6.1729.1729","article-title":"Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial","volume":"73","author":"Storb","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.06.004_bib8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S1083-8791(00)70007-3","article-title":"Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: results of\u00a0a prospective double-blind randomized trial","volume":"6","author":"Chao","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.06.004_bib9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/bbmt.2001.v7.pm11349809","article-title":"Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation","volume":"7","author":"Ho","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.06.004_bib10","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.bmt.1705513","article-title":"Acute renal failure following myeloablative autologous and allogeneic hematopoietic cell transplantation","volume":"38","author":"Lopes","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.06.004_bib11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0009-9120(98)00045-9","article-title":"Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression","volume":"31","author":"Sehgal","year":"1998","journal-title":"Clin Biochem"},{"key":"10.1016\/j.bbmt.2012.06.004_bib12","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.4049\/jimmunol.162.5.2775","article-title":"Inhibition of cell cycle\u00a0progression by rapamycin induces T cell clonal anergy even in the presence of costimulation","volume":"162","author":"Powell","year":"1999","journal-title":"J Immunol"},{"issue":"10 suppl","key":"10.1016\/j.bbmt.2012.06.004_bib13","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.transproceed.2008.10.010","article-title":"T-regulatory cells-what relationship with immunosuppressive agents?","volume":"40","author":"Wekerle","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bbmt.2012.06.004_bib14","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1097\/01.tp.0000185299.72295.90","article-title":"Low-dose radiation plus rapamycin promotes long-term bone marrow chimerism","volume":"80","author":"Powell","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2012.06.004_bib15","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/sj.bmt.1703574","article-title":"Rapamycin and T cell costimulatory blockade as post-transplant treatment promote fully MHC-mismatched allogeneic bone marrow engraftment under irradiation-free conditioning therapy","volume":"29","author":"Wu","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.06.004_bib16","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bbmt.2003.12.305","article-title":"Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation","volume":"10","author":"Cutler","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.06.004_bib17","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1182\/blood-2009-03-207563","article-title":"A phase II pilot study of tacrolimus\/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens","volume":"115","author":"Rodriguez","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.06.004_bib18","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1182\/blood-2006-09-046219","article-title":"Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation","volume":"109","author":"Cutler","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.06.004_bib19","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1182\/blood-2008-07-169342","article-title":"Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation","volume":"112","author":"Cutler","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.06.004_bib20","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1182\/blood.V98.10.2942","article-title":"Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)","volume":"98","author":"Bacigalupo","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.06.004_bib21","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.bbmt.2008.05.010","article-title":"Transplantation from matched siblings using once-daily intravenous busulfan\/fludarabine with thymoglobulin: a myeloablative regimen with low nonrelapse mortality in all but older patients with high-risk disease","volume":"14","author":"Russell","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.06.004_bib22","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.06.004_bib23","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.06.004_bib24","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1182\/blood-2009-10-249128","article-title":"Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia","volume":"115","author":"Litzow","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.06.004_bib25","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3324\/haematol.2008.000927","article-title":"Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation","volume":"94","author":"Kr\u00f6ger","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2012.06.004_bib26","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1182\/blood-2010-10-265603","article-title":"Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns","volume":"117","author":"Gupta","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.06.004_bib27","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1200\/JCO.2009.27.1460","article-title":"Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia","volume":"28","author":"Gyurkocza","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2012.06.004_bib28","first-page":"1085","article-title":"Allogeneic bone marrow transplantation for secondary leukemia or myelodysplasia","volume":"84","author":"Witherspoon","year":"1999","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2012.06.004_bib29","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1200\/JCO.2000.18.5.963","article-title":"Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia:\u00a0a long-term study of 70 patients-report of the French society of bone marrow transplantation","volume":"18","author":"Yakoub-Agha","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2012.06.004_bib30","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.bbmt.2009.10.025","article-title":"Outcome of transplantation for myelofibrosis","volume":"16","author":"Ballen","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.06.004_bib31","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1182\/blood-2005-02-0596","article-title":"Myeloablative allogeneic hematopoietic stem cell transplantation for non-Hodgkin lymphoma: a nationwide survey in Japan","volume":"108","author":"Kim","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.06.004_bib32","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1182\/blood-2009-05-206821","article-title":"Allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: ready for prime time?","volume":"114","author":"Delgado","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.06.004_bib33","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1200\/JCO.2007.15.4757","article-title":"Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning","volume":"26","author":"Sorror","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2012.06.004_bib34","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.3109\/10428194.2011.575967","article-title":"Predictive factors for successful salvage high-dose therapy in patients with multiple myeloma relapsing after autologous blood stem cell transplantation","volume":"52","author":"Fenk","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2012.06.004_bib35","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1038\/sj.leu.2402645","article-title":"Features of large granular lymphocytes (LGL) expansion following allogeneic stem cell transplantation: a long-term analysis","volume":"16","author":"Mohty","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2012.06.004_bib36","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.bmt.1704493","article-title":"Cyclosporine and\u00a0mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies","volume":"33","author":"Rodriguez","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.06.004_bib37","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.bbmt.2010.01.010","article-title":"A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft-versus-host disease prophylaxis","volume":"16","author":"Perkins","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.06.004_bib38","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/bmt.2010.167","article-title":"Tacrolimus and mycofenolate mofetil as GvHD prophylaxis following nonmyeloablative conditioning and unrelated hematopoietic SCT for adult patients with advanced hematologic diseases","volume":"46","author":"Zohren","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.06.004_bib39","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.bbmt.2008.02.009","article-title":"Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors","volume":"14","author":"Furlong","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.06.004_bib40","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/bmt.2009.112","article-title":"Thymoglobulin, CYA and mycophenolate mofetil as GVHD prophylaxis for reduced-intensity unrelated donor hematopoietic cell transplantation: beneficial effect seen on chronic GVHD","volume":"45","author":"Rodriguez","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.06.004_bib41","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1200\/JCO.2010.30.6357","article-title":"Prophylaxis of graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I\/II controlled, adaptively randomized study","volume":"29","author":"Parmar","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2012.06.004_bib42","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1182\/blood-2003-02-0489","article-title":"Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation","volume":"102","author":"Antin","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.06.004_bib43","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.bbmt.2005.12.034","article-title":"Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation","volume":"12","author":"Bacigalupo","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.06.004_bib44","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.1182\/blood-2011-01-329821","article-title":"Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius","volume":"117","author":"Socie\u00e9","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.06.004_bib45","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.exphem.2010.08.012","article-title":"Reduced-intensity conditioning with Fludarabin, oral Busulfan, and thymoglobulin allows long-term disease control and low transplant-related mortality in patients with hematological malignancies","volume":"38","author":"Blaise","year":"2010","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2012.06.004_bib46","first-page":"931","article-title":"Rabbit-immunoglobulin G levels in patients receiving thymoglobulin as part of conditioning before unrelated donor stem cell transplantation","volume":"90","author":"Remberger","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2012.06.004_bib47","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.bbmt.2010.09.017","article-title":"Prophylaxis with\u00a0sirolimus and tacrolimus \u00b1 antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation","volume":"17","author":"Rosenbeck","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.06.004_bib48","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00007890-198901000-00012","article-title":"Evidence that large granular lymphocytes of donor origin mediate acute graft-versus-host disease","volume":"47","author":"Ferrara","year":"1989","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2012.06.004_bib49","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1365-2141.1995.tb05150.x","article-title":"Expansion of CD8+CD57+ T cells after allogeneic BMT is related with a low incidence of relapse and with cytomegalovirus infection","volume":"90","author":"Dolstra","year":"1995","journal-title":"Br J Haematol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879112002388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879112002388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:43:30Z","timestamp":1761057810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879112002388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S1083879112002388"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2012.06.004","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-Thymocyte Globulin (Thymoglobulin), Tacrolimus, and Sirolimus as Acute Graft-versus-Host Disease Prophylaxis for Unrelated Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2012.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}